Unified Patent Court: An experience worth repeating?
While it remains a little early to draw clear conclusions as to trends, as time goes on, some companies are rapidly racking up experience of the Unified Patent Court.
Panasonic, for example, used the UPC to open up a new front in its Standard Essential Patent battle with OPPO and Xiaomi.
Abbott Laboratories, in various forms, appears to have been the most frequent flier in terms of court hearings, with cases concerning continuous glucose monitoring against SiBio and DexCom, perhaps reflecting the Medtech industry’s investment in the UP/UPC system, as backed up by the UP figures above.
While the hearings so far have been held in first instance Divisions in Germany, France and at the Court of Appeal in Luxembourg, use is being made of much of the full geographical of the courts, and it seems the Europe-wide system is just warming up.
My colleagues and I are keeping a close eye on how the courts are being used and will report any trends as they emerge.
Want to know more?
For more information on the Unitary Patent or the Unified Patent Court, please contact our experts at upc@hlk-ip.com.